Nevertheless, these findings suggest that KL-VSHET+ exerts an APOE ε4-genotype dependent protective effect on CSF Tau and pTau concentrations and on subsequent cognitive decline in older cognitively normal participants susceptible to AD. The gene discussed is MAPT; the disease is Mental deterioration.